Episode 113 - Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis

The Rounds Table

Content provided by Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

18d ago 9:15

MP3•Episode home

Send us a text

Welcome back Rounds Table Listeners! We are back today with a solo episode with Dr. Mike Fralick. This week, he discusses a recently published trial exploring the role of high-dose Vitamin D therapy in reducing disease activity in patients with clinically isolated syndrome (CIS) typical of multiple sclerosis (MS). Here we go!

High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Trial (0:00 – 7:35).

Announcements (7:36 – 9:15):

Canadian physicians, 2025 CMPA Council elections are underway in Alberta and Ontario! View the candidates and cast your ballot here.
Check out Dr. Yatin Chada's podcast, beyondMD!

And we've launched qMonthly, a monthly blog highlighting headliners and hidden gem trials published each month. Check it out here!

Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods

371 episodes

#Dr. John Fralick #Dr. Michael Fralick #Dr. John Fralick and Dr. Michael Fralick #Fitness #Medicine #Internal Medicine #Randomized Controlled Trials #Inpatient Medicine #Diabetes #Cardiology #Science #Biology #Podcasting Education